bf/NASDAQ:AURA_icon.jpeg

NASDAQ:AURA

Aura Biosciences, Inc.

  • Stock

USD

Last Close

5.41

06/11 21:00

Market Cap

367.12M

Beta: -

Volume Today

157.64K

Avg: 116.01K

PE Ratio

−3.16

PFCF: −5.86

    Description

    Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular onc...Show More

    Earnings

    Earnings per Share (Estimate*)

    -25-20-15-10-52020-03-302020-12-312021-09-302022-12-302024-05-062024-11-14

    Revenue (Estimate*)

    0.000.000.010.010.012020-03-302020-12-312021-09-302022-12-302024-05-062024-11-14

    *Estimate based on analyst consensus